The tweet was deleted by the author.
But we saved everything 🙂.
Eli Lilly breaks ground on new Houston manufacturing site as stock edges higher
Eli Lilly announced a $6.5 billion groundbreaking for a new manufacturing facility in Houston, Texas, as part of its $50 billion push to expand U.S. drug production and job creation. Shares edge higher on the day, trading at $1,170.
LLY price prediction
Current price:
$1,411.2
-6.3550
0.45%
Closed
11/02
Daily range
1382.02
1421.99
1421.99
Weekly range
1276.37
1436.72
1436.72
Loading...
Highlights
- Eli Lilly began construction on a $6.5 billion Houston facility to produce orforglipron and advanced therapeutics as part of a $50 billion U.S. expansion.
- Shares of Eli Lilly edged higher to $1,170 after the announcement, and the company employs 50,000 people with a $1,002.23 billion market value.
- Of 118 analysts, 93 rate Eli Lilly stock a buy and 8 recommend selling, with a median price target of $1,376.
Eli Lilly announced on September 21, 2026, that it broke ground on a new manufacturing site in Houston, Texas. The facility is part of the companys $50+ billion investment in domestic production and will create hundreds of jobs. The Houston site will manufacture Foundayo (orforglipron), as well as other small-molecule medicines and advanced therapeutics, according to ABC13 Houston.
View post on X Loading...
Upside capped at resistance as technical signals remain mixed
Price is sitting right at resistance from the weekly high at $1,170. The daily chart shows a split structure, as shares remain below the MA-50 but above the MA-20 and MA-200. Stoch RSI is in overbought territory, which limits room for further upside and contributes to the muted response in price action.
Upside odds dominate after narrow range holds at resistance
To gauge whether buyers are embracing the recent event, traders should look for a decisive move through resistance at $1,170. Shares are currently testing this level without managing to break above it. The move over the past week has been contained within a narrow range; even so, the probabilities over the coming trading week stand at 75% for upside and 25% for downside, with an expected trading range between $1,153 and $1,187. A close above $1,170 would show buyers are willing to follow through, while a drop below $1,158 would indicate the advance is being faded. On the weekly chart the longer-term picture stays firmly constructive.
Previously it was reported that the FDA approved an additional cardiovascular indication for Eli Lilly's diabetes drug, supporting a constructive long-term technical view despite mixed near-term signals. The recent manufacturing expansion in Houston adds a new dimension to the story, with traders now focusing on whether shares can decisively clear $1,170 resistance to sustain further gains.
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Subscribe to TU news
Did you like the article?
Latest Eli Lilly News
Top News
Top 5 companies for you
United States
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
Live News
